This drug entry is astuband has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
L-Baclofen
DrugBank Accession Number
DB12098
Background

L-Baclofen has been used in trials studying the treatment of Trigeminal Neuralgia.

Type
Small Molecule
Groups
Investigational
Structure
Weight
Average: 213.66
Monoisotopic: 213.0556563
Chemical Formula
C10H12ClNO2
Synonyms
  • (S)-Baclofen

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Target Actions Organism
Uγ-氨基丁酸B型receptor subunit 1
agonist
Humans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

间隙

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided byClassyfire
Description
This compound belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
Gamma amino acids and derivatives
Alternative Parents
Phenylpropanoic acids/Chlorobenzenes/Aralkylamines/Amino fatty acids/Aryl chlorides/Amino acids/Monocarboxylic acids and derivatives/Carboxylic acids/Organopnictogen compounds/Organochlorides
show 4 more
Substituents
3-phenylpropanoic-acid/Amine/Amino acid/Amino fatty acid/Aralkylamine/Aromatic homomonocyclic compound/Aryl chloride/Aryl halide/Benzenoid/Carbonyl group
show 18 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
3OHN4989XM
CAS number
66514-99-6
InChI Key
KPYSYYIEGFHWSV-MRVPVSSYSA-N
InChI
InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m1/s1
IUPAC Name
(3S)-4-amino-3-(4-chlorophenyl)butanoic acid
SMILES
NC[C@@H](CC(O)=O)C1=CC=C(Cl)C=C1

References

General References
Not Available
PubChem Compound
44600
PubChem物质
347828402
ChemSpider
40578
BindingDB
50032963
ChEMBL
CHEMBL302213
ZINC
ZINC000000085733

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Not Available Completed Treatment Trigeminal Neuralgia (TN) 1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Property Value Source
Water Solubility 0.712 mg/mL ALOGPS
logP -0.82 ALOGPS
logP -0.78 Chemaxon
logS -2.5 ALOGPS
pKa (Strongest Acidic) 3.89 Chemaxon
pKa (Strongest Basic) 9.79 Chemaxon
Physiological Charge 0 Chemaxon
Hydrogen Acceptor Count 3 Chemaxon
Hydrogen Donor Count 2 Chemaxon
Polar Surface Area 63.32 Å2 Chemaxon
Rotatable Bond Count 4 Chemaxon
Refractivity 54.83 m3·mol-1 Chemaxon
Polarizability 21.12 Å3 Chemaxon
Number of Rings 1 Chemaxon
Bioavailability 1 Chemaxon
Rule of Five Yes Chemaxon
Ghose Filter No Chemaxon
Veber's Rule No Chemaxon
MDDR-like Rule No Chemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Spectrum Spectrum Type Splash Key
Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets tounlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Agonist
General Function
G-protein coupled gaba receptor activity
Specific Function
Component of a heterodimeric G-protein coupled receptor for GABA, formed by GABBR1 and GABBR2. Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coup...
Gene Name
GABBR1
Uniprot ID
Q9UBS5
Uniprot Name
γ-氨基丁酸B型receptor subunit 1
Molecular Weight
108319.4 Da
References
  1. Malitschek B, Ruegg D, Heid J, Kaupmann K, Bittiger H, Frostl W, Bettler B, Kuhn R: Developmental changes of agonist affinity at GABABR1 receptor variants in rat brain. Mol Cell Neurosci. 1998 Sep;12(1-2):56-64. doi: 10.1006/mcne.1998.0698. [Article]

Drug created at October 20, 2016 21:20 / Updated at June 30, 2022 18:21